Radiation after treatment for prostate cancer that has spread
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether adding a targeted course of radiation to the prostate area after initial systemic treatment can improve outcomes for people with metastatic prostate cancer. It may help control the cancer by treating remaining disease after medicines have started working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate cancer based on biopsy results
- Your prostate cancer has spread to other places (metastases), either small- or larger-volume spread
- You are planning to receive or already receiving hormone therapy (ADT) and possibly anti-androgen therapy (ARAT)
- You are able to receive external beam radiation therapy (EBRT)
- You are an adult (age 18 or older) and your day-to-day ability is limited to minor or none (ECOG 0 or 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of hormone therapy plus targeted radiation for prostate cancer that has spread to a few spots (oligometastatic). The goal is to see if less hormone therapy can still control the cancer effectively.
This trial tests whether adding radiation to the prostate and to any remaining cancer spots can help when hormone therapy alone hasn't fully controlled the cancer. It is for men whose PSA remains slightly elevated after six months of initial hormone treatment.
This study tests whether radiation therapy to the pelvis after prostate removal helps men whose cancer was found in nearby lymph nodes. The goal is to prevent cancer from coming back and improve survival.
This trial tests whether radiation therapy can help treat prostate cancer that has spread to only a few places in the body (oligometastatic). It aims to see if targeting both the prostate and the small number of metastases can improve outcomes.
This trial studies the use of radiation to the prostate and to all visible spots where cancer has spread, in men who have up to 10 small areas of spread when first diagnosed. The goal is to see if this approach can help control the cancer.
This Phase 2 trial tests a radiation-focused approach for people with newly diagnosed (de novo) prostate cancer that has spread to a small number of spots, especially in bone. It aims to see how well the treatment controls the cancer while keeping side effects manageable.
Hear when a new Prostate Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.